Plant for production of Penicillin G, Clavulanic acid to begin soon: DoP
New Delhi: The production plant for Clavulanic Acid to make Augmentin used for the treatment of various bacterial infections will begin soon, Dr Arunish Chawla, Secretary Department of Pharmaceuticals Ministry of Chemical and Fertilizers informed on Tuesday.
"Production Linked Incentive scheme for bulk drugs and under that scheme, huge investment has come in, and Penicillin G and Clavulanic would now be manufactured in India. Hopefully these plants will be commissioned and inaugurated soon," s peaking with ANI she said.
"Half the antibiotics in the market are beta lactam antibiotics. They are basically based on Penicillin G and Clavulanic acid. These are core or key drug intermediates, key starting materials. They are also called bulk drugs. We used to manufacture them at one time, but we lost it to foreign competition." she added.
"We are very happy to announce that the PLI, or the Production linked incentive scheme for bulk drugs has been a success and under that scheme, huge investment has come in, and Penicillin G and Clavulanic would now be made in India," she further stated.
The secretary said that last year India had achieved trade balance in the export and import of bulk drugs.
"In India, bulk drugs should be seen on an aggregate basis. Last year, we achieved trade balance, which means we exported as many bulk drugs as we imported, but certain molecules continue to be imported from one particular country, which means import concentration that potentially could disrupt supply chains when the time comes", Chawla said.
"We need to diversify the value chains for these critical bulk drugs. The PLI scheme has provided incentive so that manufacturing on key starting materials for antibiotics can happen in India, and that's going to commence very soon," she added.
Penicillin G and Clavulanic Acid are key ingredients in the antibiotic Augmentin and the commissioning of the plant will thereby reduce India's dependency on China.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.